Bangkok Dusit Medical Ser... (BDUUF)
PNK: BDUUF
· Real-Time Price · USD
0.66
0.00 (0.00%)
At close: May 06, 2025, 10:00 PM
Bangkok Dusit Medical Services Public Income Statement
Financials in THB. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 27.4B | 28.15B | 25.7B | 26.61B | 26.34B | 26.42B | 24.08B | 24.01B | 23.48B | 23.7B | 21.77B | 22.99B | 21.6B | 19.66B | 17.16B | 16.03B |
Cost of Revenue | 17.04B | 17.63B | 16.66B | 16.74B | 16.39B | 16.47B | 15.43B | 15.12B | 14.75B | 14.98B | 14.15B | 14.45B | 13.53B | 13.12B | 11.76B | 11.05B |
Gross Profit | 10.37B | 10.52B | 9.04B | 9.87B | 9.96B | 9.95B | 8.65B | 8.89B | 8.72B | 8.72B | 7.63B | 8.54B | 8.07B | 6.54B | 5.4B | 4.98B |
Operating Income | 5.32B | 5.61B | 4.27B | 4.98B | 5.16B | 5.13B | 4.07B | 4.57B | 4.16B | 4.51B | 3.64B | 4.68B | 3.66B | 3.52B | 2.1B | 1.95B |
Interest Income | 39.02M | 40.17M | 47.46M | 48.15M | 52.02M | 48.16M | 47.53M | 25.76M | 31.87M | 18.93M | 16.46M | 12.57M | 13.98M | 13.1M | 32.7M | 13.36M |
Pretax Income | 5.28B | 5.57B | 4.22B | 5.25B | 5.11B | 5.08B | 4B | 4.47B | 4.03B | 4.39B | 3.51B | 4.55B | 3.51B | 3.36B | 1.95B | 1.77B |
Net Income | 4.33B | 4.25B | 3.33B | 4.07B | 3.95B | 3.89B | 3.05B | 3.47B | 3.11B | 3.39B | 2.66B | 3.44B | 2.64B | 2.51B | 1.45B | 1.34B |
Selling & General & Admin | 5.48B | 5.31B | 5.15B | 4.89B | 5.19B | 5.11B | 4.88B | 4.63B | 4.93B | 4.5B | 4.2B | 4.02B | 4.69B | 3.51B | 3.54B | 3.28B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -433.78M | -404.75M | -377.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 5.04B | 4.91B | 4.77B | 4.89B | 4.81B | 4.82B | 4.59B | 4.33B | 4.57B | 4.21B | 3.99B | 3.85B | 4.41B | 3.02B | 3.31B | 3.03B |
Interest Expense | 107.87M | 102.42M | 110.56M | 112.54M | 126.19M | 122.22M | 134.18M | 164M | 168.58M | 154.03M | 151.19M | 158.27M | 172.9M | 172.5M | 188.12M | 194.95M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 22.08B | 22.54B | 21.43B | 21.63B | 21.2B | 21.29B | 20.02B | 19.45B | 19.32B | 19.19B | 18.14B | 18.3B | 17.93B | 16.15B | 15.07B | 14.08B |
Income Tax Expense | 840.6M | 1.15B | 756.08M | 1.04B | 1.04B | 1.02B | 812.39M | 879.78M | 805.57M | 823.81M | 695.2M | 902.57M | 745.71M | 644.89M | 382.79M | 329.98M |
Shares Outstanding (Basic) | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B |
Shares Outstanding (Diluted) | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B | 15.89B |
EPS (Basic) | 0.27 | 0.27 | 0.21 | 0.26 | 0.25 | 0.24 | 0.19 | 0.22 | 0.20 | 0.21 | 0.17 | 0.22 | 0.17 | 0.16 | 0.09 | 0.08 |
EPS (Diluted) | 0.27 | 0.27 | 0.21 | 0.26 | 0.25 | 0.24 | 0.19 | 0.22 | 0.20 | 0.21 | 0.17 | 0.22 | 0.17 | 0.16 | 0.09 | 0.08 |
EBITDA | 6.99B | 7.22B | 5.84B | 6.46B | 6.74B | 6.67B | 5.58B | 6.06B | 5.68B | 6.03B | 5.15B | 6.19B | 5.24B | 5.13B | 3.72B | 3.54B |
EBIT | 5.39B | 5.67B | 4.33B | 5.37B | 5.24B | 5.2B | 4.13B | 4.63B | 4.2B | 4.54B | 3.67B | 4.7B | 3.69B | 3.54B | 2.14B | 1.96B |
Depreciation & Amortization | 1.6B | 1.55B | 1.5B | 1.48B | 1.5B | 1.47B | 1.45B | 1.43B | 1.48B | 1.49B | 1.49B | 1.49B | 1.56B | 1.6B | 1.58B | 1.58B |